全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Long-Term Observation of the Epidemiology and Survival of Osteosarcoma in a Rural Area of Japan

DOI: 10.4236/ojo.2026.167034, PP. 367-376

Keywords: Epidemiology, Osteosarcoma, Rural Area, Survival

Full-Text   Cite this paper   Add to My Lib

Abstract:

Objectives: No definitive risk factors for osteosarcoma have been identified. To assess regional differences, it is essential to minimize racial and other biases. However, few studies have examined this issue with minimal bias. This study aimed to evaluate regional variations in the incidence and characteristics of osteosarcoma in a rural prefecture with limited population mobility within ethnically homogeneous Japan. Subject and Methods: We retrospectively identified 40 patients with primary osteosarcoma who received treatment at our hospital from 2000 to 2024. Clinical data were collected. Akita City, the prefectural capital and most populous city in Akita Prefecture, was compared with other cities, towns, villages, and regions regarding incidence and prognosis. We also examined poor prognostic factors across all cases. Results: The incidence rate in Area 2 was significantly higher than that in Area 1 (P = 0.0269). Across municipalities, Oga City in Area 2 and Yuzawa City in Area 5 exhibited significantly higher incidence rates than Akita City (P = 0.0243 and P = 0.0477). Kaplan-Meier analysis comparing the prognosis of Area 1 with Areas 2 and 5 showed that only Area 2 had a significantly worse prognosis than Area 1. Univariate analysis of prognostic factors demonstrated that surgical treatment was the sole factor associated with improved prognosis. Conclusion: These findings suggest the existence of regional differences in the incidence and characteristics of osteosarcoma.

References

[1]  Gelberg, K., Fitzgerald, E., Hwang, S. and Dubrow, R. (1997) Growth and Development and Other Risk Factors for Osteosarcoma in Children and Young Adults. International Journal of Epidemiology, 26, 272-278.
https://doi.org/10.1093/ije/26.2.272
[2]  Zhang, C., Morimoto, L.M., de Smith, A.J., Hansen, H.M., Gonzalez‐Maya, J., Endicott, A.A., et al. (2018) Genetic Determinants of Childhood and Adult Height Associated with Osteosarcoma Risk. Cancer, 124, 3742-3752.
https://doi.org/10.1002/cncr.31645
[3]  Parkin, D.M., Stiller, C.A. and Nectoux, J. (1993) International Variations in the Incidence of Childhood Bone Tumours. International Journal of Cancer, 53, 371-376.
https://doi.org/10.1002/ijc.2910530305
[4]  Katzman, S.S. and Johnston, J.O. (1991) Epidemiology of Primary Osteogenic Sarcoma in the San Francisco Bay Area of California. Clinical Orthopaedics and Related Research, 263, 227-232.
https://doi.org/10.1097/00003086-199102000-00028
[5]  Bovill, E.G. and Subramanian, N. (1975) An Epidemiologic Study of Osteogenic Sarcoma in Malaysia. Clinical Orthopaedics and Related Research, 113, 119-127.
https://doi.org/10.1097/00003086-197511000-00017
[6]  Hirano, T., Yoshida, G., Baba, H., Iwasaki, K., Kumashiro, T. and Soda, M. (1995) Incidence of Osteosarcoma in Nagasaki. Seikeigeka to Saigaigeka, 44, 421-423. (In Japanese).
[7]  WHO Classification of Tumours Editorial Board (2020) Soft Tissue and Bone Tumours. WHO Classification of Tumours. 5th Edition, IARC Press.
[8]  Rosen, G., Caparros, B., Huvos, A.G., Kosloff, C., Nirenberg, A., Cacavio, A., et al. (1982) Preoperative Chemotherapy for Osteogenic Sarcoma: Selection of Postoperative Adjuvant Chemotherapy Based on the Response of the Primary Tumor to Preoperative Chemotherapy. Cancer, 49, 1221-1230.
https://doi.org/10.1002/1097-0142(19820315)49:6<1221::aid-cncr2820490625>3.0.co;2-e
[9]  Enneking, W.F., Spanier, S.S. and Goodman, M.A. (1980) A System for the Surgical Staging of Musculoskeletal Sarcoma. Clinical Orthopaedics and Related Research, 153, 106-120.
https://doi.org/10.1097/00003086-198011000-00013
[10]  Iwamoto, Y., Tanaka, K., Isu, K., Kawai, A., Tatezaki, S., Ishii, T., et al. (2009) Multiinstitutional Phase II Study of Neoadjuvant Chemotherapy for Osteosarcoma (NECO Study) in Japan: NECO-93J and Neco-95j. Journal of Orthopaedic Science, 14, 397-404.
https://doi.org/10.1007/s00776-009-1347-6
[11]  Iwamoto, Y. and Tanaka, K. (2012) The Activity of the Bone and Soft Tissue Tumor Study Group of the Japan Clinical Oncology Group. Japanese Journal of Clinical Oncology, 42, 467-470.
https://doi.org/10.1093/jjco/hys059
[12]  Karimi, A., Ebrahimpour, A., Sadighi, M., Chehrassan, M., Biglari, F., Jafari Kafia-badi, M., Akbari, M.E. and Azizmohammad Looha, M. (2023) Descriptive Epidemiology and Survival Rate of Osteosarcoma: The First National Population-Based Study in the Middle East (2008-2014). The Archives of Bone and Joint Surgery, 11, 649-657.
[13]  Sadykova, L.R., Ntekim, A.I., Muyangwa-Semenova, M., Rutland, C.S., Jeyapalan, J.N., Blatt, N., et al. (2020) Epidemiology and Risk Factors of Osteosarcoma. Cancer Investigation, 38, 259-269.
https://doi.org/10.1080/07357907.2020.1768401
[14]  Hu, X., Fujiwara, T., Houdek, M.T., Chen, L., Huang, W., Sun, Z., et al. (2022) Impact of Racial Disparities and Insurance Status in Patients with Bone Sarcomas in the USA: A Population-Based Cohort Study. Bone & Joint Research, 11, 278-291.
https://doi.org/10.1302/2046-3758.115.bjr-2021-0258.r2
[15]  Tsuchie, H., Emori, M., Nagasawa, H., Miyakoshi, N., Murahashi, Y., Shimizu, J., et al. (2019) Prognosis of Primary Osteosarcoma in Elderly Patients: A Comparison between Young and Elderly Patients. Medical Principles and Practice, 28, 425-431.
https://doi.org/10.1159/000500404

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133